3D-MOFIB plans to begin with scleroderma and pulmonary fibrosis associated with Hermansky–Pudlak syndrome, screening compounds and molecular activity in patient-derived models to explore shared fibrosis mechanisms and organ-specific differences.
The human-derived fibrosis model plan and mouse placental experiment are distinct studies. They are connected through the question of surrounding conditions as well as cell-intrinsic differences, not evidence about each other’s pathology or drug effects.
Transplanted neural tissue and cultured fibrosis models have different uses. The comparison concerns evaluating the environment and function of interest, not cellular origin alone.
The physiological biomarker study of antidepressants and fibrosis models differ in disease and measurement method. They share the question of what must be established before a measurable difference can guide treatment selection.
Allow this site to record page views, reading progress, a broad referral source and the ID of a prepared editorial post link? Reading and following cards work without this. Hosting-provider traffic logs are separate. Details & settings